Consequently, HSF‐1 has garnered significant attention as a promising therapeutic target for various cancer types,66, 68, 69, 70 with HSF‐1 inhibitors holding promise as potential antitumor agents, increasing the efficacy of HSP90 inhibitors (Figure 1). Here, HSP90AA1 is linked to cancer.